· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
NUVATION BIO, INC. — NUVATION BIO, INC. 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250924113835NAL0002990691001
NUVATION BIO, INC.
Form 5500-SF
FILING_RECEIVED
NUVATION BIO, INC. 401(K) PLAN
401(k) retirement plan
Signals · 1
No auditor on file
Active participants
144
Accounts w/ balance
153
Plan assets (EOY)
$9.4M
Net assets (EOY)
$9.4M
Plan health score (directional)
77
/ 100
Grade B
Above-average plan
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
60
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
NUVATION BIO, INC.
.
Find decision makers
Plan sponsor
Name
NUVATION BIO, INC.
EIN
85-0862255
Address
60 SPEAR ST 10TH FLOOR · SAN FRANCISCO, CA · 94105
Phone
(415) 793-0977
Industry
Manufacturing
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-09-24
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Manufacturing plans
THEPHAMANETWORK LLC
THEPHAMANETWORK LLC 401(K) PROFIT SHARING PLAN AND TRUST
$9.4M · 35 participants
BRII BIOSCIENCES
BRII BIOSCIENCES 401(K) PLAN
$9.3M · 25 participants
KALVISTA PHARMACEUTICALS, INC.
KALVISTA PHARMACEUTICALS, INC. 401(K) PLAN
$9.5M · 110 participants
BAYER CORPORATION
MONSANTO CARIBE RETIREMENT SAVINGS PLAN
$9.5M · 313 participants
SA SCIENTIFIC, LTD.
SAS 401(K) PLAN
$9.7M · 60 participants
100
Knocking points off
No independent qualified public accountant (IQPA) named.
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
SCILEX PHARMACEUTICALS INC.
SCILEX HOLDING COMPANY 401(K) PLAN
$9.2M · 118 participants
Large plans in California
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND
$215.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND E
$190.9B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
EQUITY INDEX FUND F
$188.1B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
RUSSELL 1000 INDEX FUND
$187.7B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
CASH EQUIVALENT FUND II
$125.0B
BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
BLACKROCK MSCI ACWI EX-US IMI INDEX FUND E
$88.3B